Amphastar Pharmaceuticals, Inc. (AMPH) Revenue 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$719.9MFY2025 · since FY2016: $255.2M → $719.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $719.9M | -1.7% |
| FY2024 | $732.0M | +13.6% |
| FY2023 | $644.4M | +29.1% |
| FY2022 | $499.0M | +14.0% |
| FY2021 | $437.8M | +25.1% |
| FY2020 | $349.8M | +8.5% |
| FY2019 | $322.4M | +9.4% |
| FY2018 | $294.7M | +22.7% |
| FY2017 | $240.2M | -5.9% |
| FY2016 | $255.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice